Exploring Safety & Clinical Benefit of Anti-Influenza Immune Globulin Intravenous in Hospitalized Adults With Influenza A
Conditions: Influenza A H3N2; Influenza A H1N1 Interventions: Biological: FLU-IGIV; Other: Placebo for FLU-IGIV Sponsor: Emergent BioSolutions Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 19, 2017 Category: Research Source Type: clinical trials